Favorable Response to Type 2 Inhibitors in Patients With Darier Disease.
Sign Up to like & getrecommendations! Published in 2024 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2024.2298
Abstract: This case report describes 2 female patients who both presented with severe and recalcitrant Darier disease who were treated with type 2 inflammation inhibitors. read more here.
Keywords: inhibitors patients; disease; response type; type inhibitors ... See more keywords
Abstract PO3-05-11: Enhancing the interpretation of real-world quality of life (QoL) in patients (pts) with hormone receptor positive human epidermal growth factor 2 negative (HR+/HER2−) advanced breast cancer (ABC) enrolled in the POLARIS trial
Sign Up to like & getrecommendations! Published in 2024 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs23-po3-05-11
Abstract: Background POLARIS is a prospective, observational real-world study of pts with HR+/HER2− ABC receiving palbociclib in routine clinical practice. We have previously shown that palbociclib treatment did not have any significant adverse impact on pt… read more here.
Keywords: month; cancer; real world; qol ... See more keywords